Home / UNC13B Knockout Cell Lines

UNC13B Knockout Cell Lines

Gene: UNC13B

Official Full Name: unc-13 homolog Bprovided by HGNC

Gene Summary: This gene is expressed in the kidney cortical epithelial cells and is upregulated by hyperglycemia. The encoded protein shares a high level of similarity to the rat homolog, and contains 3 C2 domains and a diacylglycerol-binding C1 domain. Hyperglycemia increases the levels of diacylglycerol, which has been shown to induce apoptosis in cells transfected with this gene and thus contribute to the renal cell complications of hyperglycemia. Studies in other species also indicate a role for this protein in the priming step of synaptic vesicle exocytosis. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO31801 UNC13B Knockout cell line (HeLa) Human UNC13B 1:3~1:6 Negative Online Inquiry
KO31802 UNC13B Knockout cell line (HCT 116) Human UNC13B 1:2~1:4 Negative Online Inquiry
KO31803 UNC13B Knockout cell line (HEK293) Human UNC13B 1:3~1:6 Negative Online Inquiry
KO31804 UNC13B Knockout cell line (A549) Human UNC13B 1:3~1:4 Negative Online Inquiry

Background

UNC13B Gene Knockout Cell Lines represent a significant advancement in cellular biology, designed to facilitate the study of synaptic transmission and neurotransmitter release through the specific inactivation of the UNC13B gene. This gene encodes a crucial protein involved in the docking of synaptic vesicles at the presynaptic membrane, making it essential for synaptic function. By employing CRISPR/Cas9 technology, these knockout cell lines provide researchers with a robust model to investigate the molecular underpinnings of synaptic signaling, neurodevelopmental disorders, and potential therapeutic targets for neurological diseases.

The primary function of UNC13B Gene Knockout Cell Lines is to enable the systematic analysis of synaptic physiology, plasticity, and signaling pathways downstream of neurotransmitter release. By knocking out the UNC13B gene, researchers can directly observe alterations in synaptic function and delineate the roles of this protein in various neuronal contexts. This experimental framework promotes insights into the pathophysiology of conditions such as epilepsy, autism spectrum disorders, and other neuropsychiatric diseases.

The scientific importance of these cell lines lies not only in their utility for basic research but also in their potential for translational studies in clinical settings. With their capability to model human neuronal activity and dysfunction, they serve as valuable platforms for drug discovery and the screening of pharmacological agents aimed at restoring synaptic function.

Compared to traditional wild-type cell lines, UNC13B Gene Knockout Cell Lines offer distinct advantages, including precise genetic editing, reproducible experimental results, and a defined model system that minimizes inter-sample variability. These features help enhance the reliability of research findings, making them an invaluable tool for laboratories focused on neuroscience and cellular biology.

For researchers and clinicians alike, investing in UNC13B Gene Knockout Cell Lines holds significant value as they enable more sophisticated experiments that can lead to groundbreaking discoveries in the neurosciences. Supported by our company’s extensive expertise in genetic engineering and advanced cell line development, we are committed to providing cutting-edge biological products that empower the scientific community to push the boundaries of research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.